BIOMAT Database Logo BIOMAT Database Logo

Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. 1986

L M Souza, and T C Boone, and J Gabrilove, and P H Lai, and K M Zsebo, and D C Murdock, and V R Chazin, and J Bruszewski, and H Lu, and K K Chen, and J Barendt, and E Platzer, and M A S Moore, and R Mertelsmann, and K Welte

Experiments were conducted to isolate and characterize the gene and gene product of a human hematopoietic colony-stimulating factor with pluripotent biological activities. This factor has the ability to induce differentiation of a murine myelomonocytic leukemia cell line WEHI-3B(D+) and cells from patients with newly diagnosed acute nonlymphocytic leukemia (ANLL). A complementary DNA copy of the gene encoding a pluripotent human granulocyte colony-stimulating factor (hG-CSF) was cloned and expressed in Escherichia coli. The recombinant form of hG-CSF is capable of supporting neutrophil proliferation in a CFU-GM assay. In addition, recombinant hG-CSF can support early erythroid colonies and mixed colony formation. Competitive binding studies done with 125I-labeled hG-CSF and cell samples from two patients with newly diagnosed human leukemias as well as WEHI-3B(D+) cells showed that one of the human leukemias (ANLL, classified as M4) and the WEHI-3B(D+) cells have receptors for hG-CSF. Furthermore, the murine WEHI-3B(D+) cells and human leukemic cells classified as M2, M3, and M4 were induced by recombinant hG-CSF to undergo terminal differentiation to macrophages and granulocytes. The secreted form of the protein produced by the bladder carcinoma cell line 5637 was found to be O-glycosylated and to have a molecular weight of 19,600.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003114 Colony-Forming Units Assay A cytologic technique for measuring the functional capacity of stem cells by assaying their activity. Clonogenic Cell Assay,Stem Cell Assay,Clonogenic Cell Assays,Colony Forming Units Assays,Colony-Forming Units Assays,Stem Cell Assays,Assay, Clonogenic Cell,Assay, Colony-Forming Units,Assay, Stem Cell,Assays, Clonogenic Cell,Assays, Colony-Forming Units,Assays, Stem Cell,Colony Forming Units Assay
D003115 Colony-Stimulating Factors Glycoproteins found in a subfraction of normal mammalian plasma and urine. They stimulate the proliferation of bone marrow cells in agar cultures and the formation of colonies of granulocytes and/or macrophages. The factors include INTERLEUKIN-3; (IL-3); GRANULOCYTE COLONY-STIMULATING FACTOR; (G-CSF); MACROPHAGE COLONY-STIMULATING FACTOR; (M-CSF); and GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; (GM-CSF). MGI-1,Macrophage-Granulocyte Inducer,Colony Stimulating Factor,Colony-Stimulating Factor,MGI-1 Protein,Myeloid Cell-Growth Inducer,Protein Inducer MGI,Cell-Growth Inducer, Myeloid,Colony Stimulating Factors,Inducer, Macrophage-Granulocyte,Inducer, Myeloid Cell-Growth,MGI 1 Protein,MGI, Protein Inducer,Macrophage Granulocyte Inducer,Myeloid Cell Growth Inducer
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli

Related Publications

L M Souza, and T C Boone, and J Gabrilove, and P H Lai, and K M Zsebo, and D C Murdock, and V R Chazin, and J Bruszewski, and H Lu, and K K Chen, and J Barendt, and E Platzer, and M A S Moore, and R Mertelsmann, and K Welte
Effect of human recombinant granulocyte/macrophage colony-stimulating factor and native granulocyte colony-stimulating factor on clonogenic leukemic blast cells.
November 1987, Cancer research,
L M Souza, and T C Boone, and J Gabrilove, and P H Lai, and K M Zsebo, and D C Murdock, and V R Chazin, and J Bruszewski, and H Lu, and K K Chen, and J Barendt, and E Platzer, and M A S Moore, and R Mertelsmann, and K Welte
Murine granulocyte colony-stimulating factor: actions on normal and leukemic cells.
August 1988, Behring Institute Mitteilungen,
L M Souza, and T C Boone, and J Gabrilove, and P H Lai, and K M Zsebo, and D C Murdock, and V R Chazin, and J Bruszewski, and H Lu, and K K Chen, and J Barendt, and E Platzer, and M A S Moore, and R Mertelsmann, and K Welte
Induction by recombinant human granulocyte colony-stimulating factor of differentiation of mouse myeloid leukemic M1 cells.
October 1986, FEBS letters,
L M Souza, and T C Boone, and J Gabrilove, and P H Lai, and K M Zsebo, and D C Murdock, and V R Chazin, and J Bruszewski, and H Lu, and K K Chen, and J Barendt, and E Platzer, and M A S Moore, and R Mertelsmann, and K Welte
High-affinity binding of granulocyte-macrophage colony-stimulating factor to normal and leukemic human myeloid cells.
February 1986, Proceedings of the National Academy of Sciences of the United States of America,
L M Souza, and T C Boone, and J Gabrilove, and P H Lai, and K M Zsebo, and D C Murdock, and V R Chazin, and J Bruszewski, and H Lu, and K K Chen, and J Barendt, and E Platzer, and M A S Moore, and R Mertelsmann, and K Welte
Granulocyte colony-stimulating factor and differentiation-induction in myeloid leukemic cells.
January 1987, International journal of cell cloning,
L M Souza, and T C Boone, and J Gabrilove, and P H Lai, and K M Zsebo, and D C Murdock, and V R Chazin, and J Bruszewski, and H Lu, and K K Chen, and J Barendt, and E Platzer, and M A S Moore, and R Mertelsmann, and K Welte
Granulocyte colony-stimulating factor receptors on human acute leukemia: biphenotypic leukemic cells possess granulocyte colony-stimulating factor receptors.
June 1992, Cancer research,
L M Souza, and T C Boone, and J Gabrilove, and P H Lai, and K M Zsebo, and D C Murdock, and V R Chazin, and J Bruszewski, and H Lu, and K K Chen, and J Barendt, and E Platzer, and M A S Moore, and R Mertelsmann, and K Welte
Flow cytometric detection of recombinant human granulocyte-colony stimulating factor binding to leukemic cells.
January 1993, Journal of clinical laboratory analysis,
L M Souza, and T C Boone, and J Gabrilove, and P H Lai, and K M Zsebo, and D C Murdock, and V R Chazin, and J Bruszewski, and H Lu, and K K Chen, and J Barendt, and E Platzer, and M A S Moore, and R Mertelsmann, and K Welte
Granulocyte colony-stimulating factor activation of Stat3 alpha and Stat3 beta in immature normal and leukemic human myeloid cells.
October 1996, Blood,
L M Souza, and T C Boone, and J Gabrilove, and P H Lai, and K M Zsebo, and D C Murdock, and V R Chazin, and J Bruszewski, and H Lu, and K K Chen, and J Barendt, and E Platzer, and M A S Moore, and R Mertelsmann, and K Welte
Effects of recombinant human granulocyte colony-stimulating factor on neutrophil function in normal rats.
December 1991, International journal of hematology,
L M Souza, and T C Boone, and J Gabrilove, and P H Lai, and K M Zsebo, and D C Murdock, and V R Chazin, and J Bruszewski, and H Lu, and K K Chen, and J Barendt, and E Platzer, and M A S Moore, and R Mertelsmann, and K Welte
Enhanced effect of mutant granulocyte-colony-stimulating factor (KW-2228) on the growth of normal and leukemic hemopoietic progenitor cells in comparison with recombinant human granulocyte-colony-stimulating factor (G-CSF).
January 1992, Acta haematologica,
Copied contents to your clipboard!